Page 65 - Vitamin D and Cancer

52 J. Thorne and M.J. Campbell

192. Banwell CM et al (2006) Altered nuclear receptor corepressor expression attenuates vitamin
D receptor signaling in breast cancer cells. Clin Cancer Res 12:2004–2013
193. Makishima M et al (2002) Vitamin D receptor as an intestinal bile acid sensor. Science
296:1313–1316
194. Banwell CM, O’Neill LP, Uskokovic MR, Campbell MJ (2004) Targeting 1alpha, 25-dihy-
droxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with
histone deacetylation inhibitors. J Steroid Biochem Mol Biol 89–90:245–249
195. Tavera-Mendoza LE et al (2008) Incorporation of histone deacetylase inhibition into the
structure of a nuclear receptor agonist. Proc Natl Acad Sci USA 105:8250–8255
196. Costa EM, Feldman D (1987) Modulation of 1, 25-dihydroxyvitamin D3 receptor binding
and action by sodium butyrate in cultured pig kidney cells (LLC-PK1). J Bone Miner Res
2:151–159
197. Gaschott T, Stein J (2003) Short-chain fatty acids and colon cancer cells: the vitamin D
receptor–butyrate connection. Recent Results Cancer Res 164:247–257
198. Daniel C, Schroder O, Zahn N, Gaschott T, Stein J (2004) p38 MAPK signaling pathway is
involved in butyrate-induced vitamin D receptor expression. Biochem Biophys Res Commun
324:1220–1226
199. Chen JS, Faller DV, Spanjaard RA (2003) Short-chain fatty acid inhibitors of histone
deacetylases: promising anticancer therapeutics? Curr Cancer Drug Targets 3:219–236
200. Gaschott T, Werz O, Steinmeyer A, Steinhilber D, Stein J (2001) Butyrate-induced differen-
tiation of Caco-2 cells is mediated by vitamin D receptor. Biochem Biophys Res Commun
288:690–696
201. Tanaka Y, Bush KK, Klauck TM, Higgins PJ (1989) Enhancement of butyrate-induced
differentiation of HT-29 human colon carcinoma cells by 1, 25-dihydroxyvitamin D3.
Biochem Pharmacol 38:3859–3865
202. Krasowski MD, Yasuda K, Hagey LR, Schuetz EG (2005) Evolutionary selection across the
nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D,
pregnane X, and constitutive androstane receptors). Nucl Recept 3:2
203. Bookout AL et al (2006) Anatomical profiling of nuclear receptor expression reveals a hier-
archical transcriptional network. Cell 126:789–799
204. Carlberg C, Dunlop TW (2006) An integrated biological approach to nuclear receptor signal-
ing in physiological control and disease. Crit Rev Eukaryot Gene Expr 16:1–22
205. Adorini L, Daniel KC, Penna G (2006) Vitamin D receptor agonists, cancer and the immune
system: an intricate relationship. Curr Top Med Chem 6:1297–1301
206. Evans RM (2005) The nuclear receptor superfamily: a rosetta stone for physiology. Mol
Endocrinol 19:1429–1438
207. Westerhoff HV, Palsson BO (2004) The evolution of molecular biology into systems biology.
Nat Biotechnol 22:1249–1252
208. Muller M, Kersten S (2003) Nutrigenomics: goals and strategies. Nat Rev Genet 4:315–322